|
BOD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.497800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.622000E-04 |
| Normal-vs-Stage2 |
5.094800E-01 |
| Normal-vs-Stage3 |
3.110600E-01 |
| Normal-vs-Stage4 |
1.123220E-01 |
| Stage1-vs-Stage2 |
4.572200E-01 |
| Stage1-vs-Stage3 |
1.873510E-02 |
| Stage1-vs-Stage4 |
4.304100E-02 |
| Stage2-vs-Stage3 |
2.276000E-01 |
| Stage2-vs-Stage4 |
8.176100E-02 |
| Stage3-vs-Stage4 |
2.335000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.049570E-01 |
| Normal-vs-AfricanAmerican |
2.614500E-02 |
| Normal-vs-Asian |
4.119800E-01 |
| Caucasian-vs-AfricanAmerican |
4.097800E-01 |
| Caucasian-vs-Asian |
3.153000E-01 |
| AfricanAmerican-vs-Asian |
2.697200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.518500E-02 |
| Normal-vs-Female |
8.551400E-01 |
| Male-vs-Female |
9.449700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.346400E-01 |
| Normal-vs-Extreme_Weight |
1.213580E-01 |
| Normal-vs-Obese |
3.154600E-01 |
| Normal-vs-Extreme_Obese |
3.356200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.889400E-01 |
| Normal_Weight-vs-Obese |
9.593800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.070800E-01 |
| Extreme_Weight-vs-Obese |
7.248000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.253600E-01 |
| Obese-vs-Extreme_Obese |
6.880600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.540200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.200000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.778400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.914400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.872800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.665600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.322600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.860100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.163000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.803600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.606790E-04 |
| Normal-VS-Type2 PRCC |
1.360360E-01 |
| Normal-VS-KIRP CIMP |
4.442200E-01 |
| Normal-VS-Unclassified PRCC |
1.578450E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.422100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.190600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.365400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.948600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.217900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.562000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.943000E-01 |
| Normal-vs-N1 |
1.793220E-01 |
| Normal-vs-N2 |
6.015400E-01 |
| N0-vs-N1 |
2.073600E-01 |
| N0-vs-N2 |
4.220400E-01 |
| N1-vs-N2 |
8.719400E-01 |
|
|
